ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 2 filers reported holding ARGENX SE in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,035,299 | +28.4% | 8,208 | 0.0% | 1.20% | +81.0% |
| Q2 2023 | $3,143,336 | +2.8% | 8,208 | 0.0% | 0.66% | -35.4% |
| Q1 2023 | $3,058,137 | -0.9% | 8,208 | 0.0% | 1.03% | -12.2% |
| Q4 2022 | $3,084,484 | +5.1% | 8,208 | 0.0% | 1.17% | +9.8% |
| Q3 2022 | $2,935,000 | -5.6% | 8,208 | 0.0% | 1.07% | +3.5% |
| Q2 2022 | $3,110,000 | -53.0% | 8,208 | -60.9% | 1.03% | -29.6% |
| Q1 2022 | $6,624,000 | -21.9% | 21,009 | -12.5% | 1.46% | -13.0% |
| Q4 2021 | $8,480,000 | – | 24,020 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |